NEED TO FIX --- Dr Neeraj Agarwal on Why PARP Inhibitor Approval in Prostate Cancer Is Slow-Moving December 5, 2020 FDA approvals for PARP inhibitors in prostate cancer treatment have taken longer than in ovarian cancer treatment. Neeraj Agarwal, MD, a professor of medicine, physician, and director of the genitourinary oncology program at the University of Utah’s Huntsman Cancer Institute, discusses the challenges associated with testing and gaining approval of new drugs in prostate cancer.Read the full article here. source: Rose McNulty - AJMC Read More About Prostate Cancer Enjoy our library of additional news articles, our Journey to ZERO blog, and our ZEROHour newsletter. ZERO in the News ZERO in the News Read features about ZERO Prostate Cancer in the news—covering events, personal stories, advocacy efforts, and more! Monthly Newsletter Monthly Newsletter ZEROHour features news about prostate cancer, updates on ZERO’s initiatives and activities, and featured stories of those impacted by the disease. Journey to ZERO Journey to ZERO Our Journey to ZERO blog features commentary and discussion about what's happening in the prostate cancer community, stories and inspiration from people impacted by the disease, and insights on news and current events. About Prostate Cancer Prostate Cancer News More for you
NEED TO FIX --- Dr Neeraj Agarwal on Why PARP Inhibitor Approval in Prostate Cancer Is Slow-Moving December 5, 2020
FDA approvals for PARP inhibitors in prostate cancer treatment have taken longer than in ovarian cancer treatment. Neeraj Agarwal, MD, a professor of medicine, physician, and director of the genitourinary oncology program at the University of Utah’s Huntsman Cancer Institute, discusses the challenges associated with testing and gaining approval of new drugs in prostate cancer.Read the full article here. source: Rose McNulty - AJMC
Read More About Prostate Cancer Enjoy our library of additional news articles, our Journey to ZERO blog, and our ZEROHour newsletter. ZERO in the News ZERO in the News Read features about ZERO Prostate Cancer in the news—covering events, personal stories, advocacy efforts, and more! Monthly Newsletter Monthly Newsletter ZEROHour features news about prostate cancer, updates on ZERO’s initiatives and activities, and featured stories of those impacted by the disease. Journey to ZERO Journey to ZERO Our Journey to ZERO blog features commentary and discussion about what's happening in the prostate cancer community, stories and inspiration from people impacted by the disease, and insights on news and current events.
Donate Now
